News > Account Activity
SaveE-mailPrintMost PopularRSSReprints

Bristol-Myers Squibb Picks MediaVest

Client spends $420 million annually in measured media

June 30, 2009

- Steve McClellan


adweek/photos/stylus/81056-bristolmyerssquibbL.jpg
NEW YORK Bristol-Myers Squibb has awarded its media assignment to Publicis Groupe's MediaVest after a review, the client has confirmed.

The company spent $420 million on measured media in 2008, according to Nielsen. Through the first four months of this year, the client spent $172 million, per Nielsen.

The incumbent on the business is WPP Group's Mindshare, which participated in the review that began in April. Other contenders included Havas' MPG. The agencies either declined comment or referred questions to the client.

A client representative confirmed the decision without further elaboration or comment.

Mindshare won the business in 2001 after a review. Previously, the company had handled its media planning and buying internally.

The company reported close to $21 billion in sales in 2008. It identifies its top selling brands as Plavix ($5.6 billion), Abilify ($2.2 billion), Avapro/Avalide ($1.3 billion), Reyataz ($1.3 billion) and Sustiva ($1.1 billion).


Bristol-Myers Squibb Picks MediaVest

Client spends $420 million annually in measured media

June 30, 2009

- Steve McClellan


adweek/photos/stylus/81056-bristolmyerssquibbL.jpg

NEW YORK Bristol-Myers Squibb has awarded its media assignment to Publicis Groupe's MediaVest after a review, the client has confirmed.

The company spent $420 million on measured media in 2008, according to Nielsen. Through the first four months of this year, the client spent $172 million, per Nielsen.

The incumbent on the business is WPP Group's Mindshare, which participated in the review that began in April. Other contenders included Havas' MPG. The agencies either declined comment or referred questions to the client.

A client representative confirmed the decision without further elaboration or comment.

Mindshare won the business in 2001 after a review. Previously, the company had handled its media planning and buying internally.

The company reported close to $21 billion in sales in 2008. It identifies its top selling brands as Plavix ($5.6 billion), Abilify ($2.2 billion), Avapro/Avalide ($1.3 billion), Reyataz ($1.3 billion) and Sustiva ($1.1 billion).


Post a Comment
Asterisk (*) is a required field.
* Author:
* Comment:
 
The opinions expressed in comments are those of the individual poster. They do not necessarily reflect the views of Adweek or Nielsen Business Media. Attacks of a personal nature and comments that are otherwise inappropriate may be removed.


Our ProductsOur Products

ADWEEK DAILY UPDATE

Receive a comprehensive roundup of the biggest stories of the day.

SUBSCRIBE

Stay connected to what's happening in the advertising industry with delivery of the print edition and complete online access.

More VideosVideo





Adweek Advertising Home | Advertising Industry News | Creative TV Advertising | Advertising Industry Community | Video Advertising | Advertising Data Center | Advertising Special Reports | Advertising Careers | Advertising Products | Advertising About Us | Advertising Business Statements | Advertising Contact Us | Advertising Opportunities | Ad Licensing | Advertiser FAQ | Advertising Magazine Subscriptions | Advertising News RSS | Online Ad Site Map | Mobile

© 2010 Adweek. All rights reserved. Terms of Use  |   Privacy Policy